Solace Behavioral Health is proud to offer Spravato as a new and highly effective treatment modality for Treatment Resistant Depression (TRD). We offer Spravato as a treatment modality because it can provide fast, effective relief from depression, anxiety, and suicidal thoughts. We ensure that all Solace Behavioral Health providers and staff have the training and experience to provide safe Spravato treatment.
What is Spravato?
The first and only NMDA receptor antagonist approved for TRD in adults. It is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. it is derived from Ketamine which has shown incredible results in the treatment of depression but because ketamine can only be used intravenously, a new form of ketamine was developed that didn’t need to be given intravenously. Spravato is designed to be delivered intra-nasally, delivered just like a common nasal decongestant.
How quick does Spravato work?
In clinical studies, improvement of depression symptoms was demonstrated at four weeks by Spravatoplus an oral antidepressant, compared with placebo nasal spray plus an oral antidepressant.
What does treatment with Spravato look like?
Because it is basically like ketamine with a more friendly route of administration, the properties are still the same as Ketamine. It still has to be given in a supervised environment with blood pressure monitoring. It can still cause some sedation and dissociation and you cannot drive home after the treatment. Treatment generally takes about 2 hours a couple of times a week and can last a few weeks.
What are the side effects of Spravato?
There are three main categories of side effects with Spravato. Because it was derived from an anesthetic agent; you have the side effects associated with anesthesia like effects such as sedation and dissociation. This is whey there is a 2 hour observation period after the administration of the drug. It also carries a risk of abuse and misuse. This is due to the potential euphoric effects of the drug. As such; the drug is always administered in a controlled setting and the client is never given the drug unsupervised. Lastly, as with any antidepressant, there is the risk of increased suicidal thoughts. Although rare, this can definitely happen with almost any anti-depressant.